Distinct modifications of hippocampal glucocorticoid receptor phosphorylation and FKBPs by lipopolysaccharide in depressive female and male rats

Abstract

Inflammation plays a critical role in pathogenesis of depression and can affect the hypothalamic-pituitary-adrenal axis activity. Accordingly, in this study we investigated the role of hippocampal glucocorticoid receptor in mediating the effects of inflammation on behaviour of female and male Wistar rats. We studied the effects of lipopolysaccharide on the levels of glucocorticoid receptors and its co-chaperones FK506 binding protein 52 and FK506 binding protein 51, the levels of glucocorticoid receptor phospho-isoforms, pGR-232 and pGR-246, and glucocorticoid receptor up-stream kinases. In order to assess transcriptional activity of glucocorticoid receptor, we measured mRNA levels of several glucocorticoid receptor-regulated genes. We demonstrated that lipopolysaccharide induced depressive-like behaviour and elevated serum corticosterone in both sexes. However, it affected glucocorticoid receptor signalling in the nucleus of females and males differently – in females it elevated levels of glucocorticoid receptors, pGR-246 and FK506 binding protein 52, while in males it decreased levels of glucocorticoid receptor, both co-chaperons and pGR-246. Alterations in pGR-246 were associated with alterations of c-Jun N-terminal kinases. Altered nuclear levels of total glucocorticoid receptors and pGR-246 were accompanied by sex-specific reduction in brain-derived neurotrophic factor and cyclooxygenase-2 mRNA and sex-unspecific reduction in the expression of p11 and glucocorticoid receptor genes. These alterations may ultimately affect different glucocorticoid receptor -associated processes involved in depressive-like behaviour in males and females.

Keywords

Lipopolysaccharide depressive-like behaviour sex glucocorticoid receptor phosphorylations FK506 binding proteins

Get full access to this article

View all access options for this article.

References

Adzic

Djordjevic

Mitic

et al (2015) The contribution of hypothalamic neuroendocrine, neuroplastic and neuroinflammatory processes to lipopolysaccharide-induced depressive-like behaviour in female and male rats: Involvement of glucocorticoid receptor and C/EBP-beta. Behav Brain Res 291: 130–139.

Anisman

Gibb

Hayley

(2008) Influence of continuous infusion of interleukin-1beta on depression-related processes in mice: Corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression. Psychopharmacology (Berl) 199: 231–244.

Arias-Negrete

Keller

Chadee

(1995) Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages. Biochem Biophys Res Commun 208: 582–589.

Beck

Vanden Berghe

Vermeulen

et al (2009) Crosstalk in inflammation: The interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. Endocr Rev 30: 830–882.

Biesmans

Matthews

Bouwknecht

et al (2016) Systematic analysis of the cytokine and anhedonia response to peripheral lipopolysaccharide administration in rats. BioMed Res Int 2016: 9085273.

Blind

Garabedian

(2008) Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes. J Steroid Biochem Mol Biol 109: 150–157.

Brkic

Petrovic

Franic

et al (2016) Male-specific effects of lipopolysaccharide on glucocorticoid receptor nuclear translocation in the prefrontal cortex of depressive rats. Psychopharmacology (Berl) 233: 3315–3330.

Campbell

Macqueen

(2004) The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci 29: 417–426.

Chen

Dang

Blind

et al (2008) Glucocorticoid receptor phosphorylation differentially affects target gene expression. Mol Endocrinol 22: 1754–1766.

10.

Cortese

Barrientos

Maier

et al (2011) Aging and a peripheral immune challenge interact to reduce mature brain-derived neurotrophic factor and activation of TrkB, PLCgamma1, and ERK in hippocampal synaptoneurosomes. J Neurosci 31: 4274–4279.

11.

Cosgrove

Mazure

Staley

(2007) Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry 62: 847–855.

12.

Dantzer

O’Connor

Freund

et al (2008) From inflammation to sickness and depression: When the immune system subjugates the brain. Nat Rev Neurosci 9: 46–56.

13.

Dong

Poellinger

Gustafsson

et al (1988) Regulation of glucocorticoid receptor expression: Evidence for transcriptional and posttranslational mechanisms. Mol Endocrinol 2: 1256–1264.

14.

Duma

Jewell

Cidlowski

(2006) Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J Steroid Biochem Mol Biol 102: 11–21.

15.

Dunn

(2000) Cytokine activation of the HPA axis. Ann N Y Acad Sci 917: 608–617.

16.

Engler

Bailey

Engler

et al (2008) Interleukin-1 receptor type 1-deficient mice fail to develop social stress-associated glucocorticoid resistance in the spleen. Psychoneuroendocrinology 33: 108–117.

17.

Galigniana

Erlejman

Monte

et al (2010) The hsp90-FKBP52 complex links the mineralocorticoid receptor to motor proteins and persists bound to the receptor in early nuclear events. Mol Cell Biol 30: 1285–1298.

18.

Girard-Joyal

Faragher

Bradley

et al (2015) Age and sex differences in c-Fos expression and serum corticosterone concentration following LPS treatment. Neuroscience 305: 293–301.

19.

Goel

Workman

Lee

et al (2014) Sex differences in the HPA axis. Compr Physiol 4: 1121–1155.

20.

Goncalves

Williams

Yip

et al (2010) The COX-2 inhibitors, meloxicam and nimesulide, suppress neurogenesis in the adult mouse brain. Br J Pharmacol 159: 1118–1125.

21.

Goppelt-Struebe

(1997) Molecular mechanisms involved in the regulation of prostaglandin biosynthesis by glucocorticoids. Biochem Pharmacol 53: 1389–1395.

22.

Guan

Fang

(2006) Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats. Brain Behav Immun 20: 64–71.

23.

Guo

Zhang

et al (2016) Probable involvement of p11 with interferon alpha induced depression. Sci Rep 6: 17029.

24.

Hill

Kwek

et al (2012) Modulatory effects of sex steroid hormones on brain-derived neurotrophic factor-tyrosine kinase B expression during adolescent development in C57Bl/6 mice. J Neuroendocrinol 24: 774–788.

25.

Hubler

Denny

Valentine

et al (2003) The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness. Endocrinology 144: 2380–2387.

26.

Irusen

Matthews

Takahashi

et al (2002) p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: Role in steroid-insensitive asthma. J Allergy Clin Immunol 109: 649–657.

27.

Ismaili

Garabedian

(2004) Modulation of glucocorticoid receptor function via phosphorylation. Ann N Y Acad Sci 1024: 86–101.

28.

Itoh

Adachi

Yasui

et al (2002) Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. Mol Endocrinol 16: 2382–2392.

29.

Kam

Szefler

Surs

et al (1993) Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 151: 3460–3466.

30.

Kessler

(2003) Epidemiology of women and depression. J Affect Disord 74: 5–13.

31.

Kojima

Morisaki

Izuhara

et al (2000) Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-kappa B activation. Oncogene 19: 1225–1231.

32.

Kumar

Mark

Ward

et al (2001) Estradiol-regulated expression of the immunophilins cyclophilin 40 and FKBP52 in MCF-7 breast cancer cells. Biochem Biophys Res Commun 284: 219–225.

33.

Laemmli

(1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685.

34.

Livak

Schmittgen

(2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–408.

35.

Lowry

Rosebrough

Farr

et al (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275.

36.

McNally

Bhagwagar

Hannestad

(2008) Inflammation, glutamate, and glia in depression: A literature review. CNS Spectr 13: 501–510.

37.

Malviya

Kelly

Greenlee

et al (2013) Estradiol stimulates an anti-translocation expression pattern of glucocorticoid co-regulators in a hippocampal cell model. Physiol Behav 122: 187–192.

38.

Mercado

Hakim

Kobayashi

et al (2012) Restoration of corticosteroid sensitivity by p38 mitogen activated protein kinase inhibition in peripheral blood mononuclear cells from severe asthma. PLoS One 7: e41582.

39.

Meyer

Schmidt

(1995) Potential mechanisms underlying autoregulation of glucocorticoid receptor mRNA levels in the DHD/K12/PROb rat colonic adenocarcinoma cell line. J Steroid Biochem Mol Biol 55: 219–228.

40.

Miller

Pariante

Pearce

(1999) Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression. Adv Exp Med Biol 461: 107–116.

41.

Miller

Webb

Copik

et al (2005) p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: Correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol Endocrinol 19: 1569–1583.

42.

Morris

Cuthbert

(2012) Research domain criteria: Cognitive systems, neural circuits, and dimensions of behavior. Dialogues Clin Neurosci 14: 29–37.

43.

Mouihate

Pittman

(2003) Neuroimmune response to endogenous and exogenous pyrogens is differently modulated by sex steroids. Endocrinology 144: 2454–2460.

44.

Moutsatsou

Psarra

Tsiapara

et al (2001) Localization of the glucocorticoid receptor in rat brain mitochondria. Arch Biochem Biophys 386: 69–78.

45.

Newton

Seybold

Kuitert

et al (1998) Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA. J Biol Chem 273: 32312–32321.

46.

Nolen-Hoeksema

(1987) Sex differences in unipolar depression: Evidence and theory. Psychol Bull 101: 259–282.

47.

Pace

Miller

(2007) Cytokine-effects on glucocorticoid receptor function: Relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 21: 9–19.

48.

Pariante

Lightman

(2008) The HPA axis in major depression: Classical theories and new developments. Trends Neurosci 31: 464–468.

49.

Pariante

Pearce

Pisell

et al (1999) The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology 140: 4359–4366.

50.

Pollak

Yirmiya

(2002) Cytokine-induced changes in mood and behaviour: Implications for ‘depression due to a general medical condition’, immunotherapy and antidepressive treatment. Int J Neuropsychopharmacol 5: 389–399.

51.

Raison

Capuron

Miller

(2006) Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol 27: 24–31.

52.

Richter

Zeuch

Riva

et al (2013) Environmental enrichment ameliorates depressive-like symptoms in young rats bred for learned helplessness. Behav Brain Res 252: 287–292.

53.

Rutledge

Cote

(2003) Mathematics of quantitative kinetic PCR and the application of standard curves. Nucleic Acids Res 31: e93.

54.

Sapolsky

Rivier

Yamamoto

et al (1987) Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238: 522–524.

55.

Schaaf

De Kloet

Vreugdenhil

(2000) Corticosterone effects on BDNF expression in the hippocampus. Implications for memory formation. Stress 3: 201–208.

56.

Simic

Maric

Mitic

et al (2013) Phosphorylation of leukocyte glucocorticoid receptor in patients with current episode of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 40: 281–285.

57.

Storer

Dickey

Galigniana

et al (2011) FKBP51 and FKBP52 in signaling and disease. Trends Endocrinol Metab 22: 481–490.

58.

Swartz

Afshari

et al (2005) Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines. Mol Hum Reprod 11: 441–450.

59.

Tatro

Everall

Kaul

et al (2009) Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: Implications for major depressive disorder. Brain Res 1286: 1–12.

60.

Vedeckis

Ali

Allen

(1989) Regulation of glucocorticoid receptor protein and mRNA levels. Cancer Res 49: 2295s–2302s.

61.

Wang

Frederick

Garabedian

(2002) Deciphering the phosphorylation “code” of the glucocorticoid receptor in vivo. J Biol Chem 277: 26573–26580.

62.

Warner-Schmidt

Chen

Zhang

et al (2010) A role for p11 in the antidepressant action of brain-derived neurotrophic factor. Biol Psychiatry 68: 528–535.

63.

Warner-Schmidt

Flajolet

Maller

et al (2009) Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation. J Neurosci 29: 1937–1946.

64.

Warner-Schmidt

Vanover

Chen

et al (2011) Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc Natl Acad Sci USA 108: 9262–9267.

65.

Wolf

Periyasamy

Hinds

Jr et al (2009) Targeted ablation reveals a novel role of FKBP52 in gene-specific regulation of glucocorticoid receptor transcriptional activity. J Steroid Biochem Mol Biol 113: 36–45.

66.

Zhang

et al (2008) p11 is up-regulated in the forebrain of stressed rats by glucocorticoid acting via two specific glucocorticoid response elements in the p11 promoter. Neuroscience 153: 1126–1134.

67.

Zhang

Shao

et al (2014) ERK MAP kinase activation in spinal cord regulates phosphorylation of Cdk5 at serine 159 and contributes to peripheral inflammation induced pain/hypersensitivity. PLoS One 9: e87788.